Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$44.00 USD
+1.05 (2.44%)
Updated Sep 24, 2024 03:59 PM ET
Pre-Market: $44.50 +0.50 (1.14%) 9:10 AM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (87 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | 0.27 | -1.06 | 61.00 |
Year Ago Quarter Estimate | 0.28 | -0.06 | 54.84 |
Next Quarter Estimate | 0.30 | -1.85 | 63.00 |
Next Year Estimate | 1.62 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 19.15 | 20.20 | 15.67 |
Next Year | 44.64 | 15.90 | 11.34 |
Last 5 Years | 9.20 | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 38.94 | -1.82 |
Price/Book (MRQ) | 7.71 | 1.65 |
Price/Cash Flow (MRFY) | 45.94 | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 21.93% | -58.89% |
Return on Equity (TTM) | 23.66% | -58.88% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.